Infant Acute Lymphoblastic Leukemia-New Therapeutic Opportunities

被引:2
作者
Kulczycka, Marika [1 ]
Derlatka, Kamila [1 ]
Tasior, Justyna [1 ]
Sygacz, Maja [1 ]
Lejman, Monika [2 ]
Zawitkowska, Joanna [3 ]
机构
[1] Med Univ Lublin, Dept Pediat Hematol Oncol & Transplantol, Student Sci Soc, PL-20093 Lublin, Poland
[2] Med Univ Lublin, Independent Lab Genet Diagnost, PL-20093 Lublin, Poland
[3] Med Univ Lublin, Dept Pediat Hematol Oncol & Transplantol, PL-20093 Lublin, Poland
关键词
acute lymphoblastic leukemia; infant; targeted therapies; STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; YOUNG-ADULTS; PEDIATRIC-PATIENTS; BLINATUMOMAB; CHEMOTHERAPY; REARRANGEMENTS; CHILDREN; MENIN; INTERFANT-99;
D O I
10.3390/ijms25073721
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Infant acute lymphoblastic leukemia (Infant ALL) is a kind of pediatric ALL, diagnosed in children under 1 year of age and accounts for less than 5% of pediatric ALL. In the infant ALL group, two subtypes can be distinguished: KMT2A-rearranged ALL, known as a more difficult to cure form and KMT2A- non-rearranged ALL with better survival outcomes. As infants with ALL have lesser treatment outcomes compared to older children, it is pivotal to provide novel treatment approaches. Progress in the development of molecularly targeted therapies and immunotherapy presents exciting opportunities for potential improvement. This comprehensive review synthesizes the current literature on the epidemiology, clinical presentation, molecular genetics, and therapeutic approaches specific to ALL in the infant population.
引用
收藏
页数:14
相关论文
共 74 条
  • [1] The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias
    Andersson, Anna K.
    Ma, Jing
    Wang, Jianmin
    Chen, Xiang
    Gedman, Amanda Larson
    Dang, Jinjun
    Nakitandwe, Joy
    Holmfeldt, Linda
    Parker, Matthew
    Easton, John
    Huether, Robert
    Kriwacki, Richard
    Rusch, Michael
    Wu, Gang
    Li, Yongjin
    Mulder, Heather
    Raimondi, Susana
    Pounds, Stanley
    Kang, Guolian
    Shi, Lei
    Becksfort, Jared
    Gupta, Pankaj
    Payne-Turner, Debbie
    Vadodaria, Bhavin
    Boggs, Kristy
    Yergeau, Donald
    Manne, Jayanthi
    Song, Guangchun
    Edmonson, Michael
    Nagahawatte, Panduka
    Wei, Lei
    Cheng, Cheng
    Pei, Deqing
    Sutton, Rosemary
    Venn, Nicola C.
    Chetcuti, Albert
    Rush, Amanda
    Catchpoole, Daniel
    Heldrup, Jesper
    Fioretos, Thoas
    Lu, Charles
    Ding, Li
    Pui, Ching-Hon
    Shurtleff, Sheila
    Mullighan, Charles G.
    Mardis, Elaine R.
    Wilson, Richard K.
    Gruber, Tanja A.
    Zhang, Jinghui
    Downing, James R.
    [J]. NATURE GENETICS, 2015, 47 (04) : 330 - U192
  • [2] Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses
    Annesley, Colleen
    Summers, Corinne
    Pulsipher, Michael A.
    Wayne, Alan S.
    Rivers, Julie
    Lamble, Adam J.
    Wilson, Ashley
    Wu, Qian Vicky
    Brand, Adam
    Mgebroff, Stephanie
    Brown, Christopher
    Lindgren, Catherine
    Park, Julie R.
    Jensen, Michael C.
    Gardner, Rebecca
    [J]. BLOOD, 2019, 134
  • [3] Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity
    Attarbaschi, Andishe
    Mann, Georg
    Koenig, Margit
    Steiner, Manuel
    Strehl, Sabine
    Schreiberhuber, Anita
    Schneider, Bjoern
    Meyer, Claus
    Marschalek, Rolf
    Borkhardt, Arndt
    Pickl, Winfried F.
    Lion, Thomas
    Gadner, Helmut
    Haas, Oskar A.
    Dworzak, Michael N.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (10) : 2988 - 2994
  • [4] Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study
    Boer, Judith M.
    Valsecchi, Maria Grazia
    Hormann, Femke M.
    Antic, Zeljko
    Zaliova, Marketa
    Schwab, Claire
    Cazzaniga, Giovanni
    Arfeuille, Chloe
    Cave, Helene
    Attarbaschi, Andishe
    Strehl, Sabine
    Escherich, Gabriele
    Imamura, Toshihiko
    Ohki, Kentaro
    Grueber, Tanja A.
    Sutton, Rosemary
    Pastorczak, Agata
    Lammens, Tim
    Lambert, Frederic
    Li, Chi Kong
    Carrillo de Santa Pau, Enrique
    Hoffmann, Steve
    Moericke, Anja
    Harrison, Christine J.
    Den Boer, Monique L.
    De Lorenzo, Paola
    Stam, Ronald W.
    Bergmann, Anke K.
    Pieters, Rob
    [J]. LEUKEMIA, 2021, 35 (10) : 2978 - 2982
  • [5] The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
    Bolouri, Hamid
    Farrar, Jason E.
    Triche, Timothy, Jr.
    Ries, Rhonda E.
    Lim, Emilia L.
    Alonzo, Todd A.
    Ma, Yussanne
    Moore, Richard
    Mungall, Andrew J.
    Marra, Marco A.
    Zhang, Jinghui
    Ma, Xiaotu
    Liu, Yu
    Liu, Yanling
    Auvil, Jaime M. Guidry
    Davidsen, Tanja M.
    Gesuwan, Patee
    Hermida, Leandro C.
    Salhia, Bodour
    Capone, Stephen
    Ramsingh, Giridharan
    Zwaan, Christian Michel
    Noort, Sanne
    Piccolo, Stephen R.
    Kolb, E. Anders
    Gamis, Alan S.
    Smith, Malcolm A.
    Gerhard, Daniela S.
    Meshinchi, Soheil
    [J]. NATURE MEDICINE, 2018, 24 (01) : 103 - +
  • [6] Use of CD19-directed CAR T-Cell Therapy in an Infant With Refractory Acute Lymphoblastic Leukemia
    Breese, Erin H.
    Krupski, Christa
    Nelson, Adam S.
    Perentesis, John P.
    Phillips, Christine L.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (04) : 152 - 154
  • [7] How I treat infant leukemia
    Brown, Patrick
    Pieters, Rob
    Biondi, Andrea
    [J]. BLOOD, 2019, 133 (03) : 205 - 214
  • [8] Treatment of infant leukemias: challenge and promise
    Brown, Patrick
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 596 - 600
  • [9] FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631
    Brown, Patrick A.
    Kairalla, John A.
    Hilden, Joanne M.
    Dreyer, ZoAnn E.
    Carroll, Andrew J.
    Heerema, Nyla A.
    Wang, Cindy
    Devidas, Meenakshi
    Gore, Lia
    Salzer, Wanda L.
    Winick, Naomi J.
    Carroll, William L.
    Raetz, Elizabeth A.
    Borowitz, Michael J.
    Small, Donald
    Loh, Mignon L.
    Hunger, Stephen P.
    [J]. LEUKEMIA, 2021, 35 (05) : 1279 - 1290
  • [10] Interaction of MLL amino terminal sequences with menin is required for transformation
    Caslini, Corrado
    Yang, Zhaohai
    El-Osta, Mohamad
    Milne, Thomas A.
    Slany, Robeft K.
    Hess, Jay L.
    [J]. CANCER RESEARCH, 2007, 67 (15) : 7275 - 7283